FERNANDEZ, Carlos,HEYRMAN, Reinilde,SULLIVAN, Eugene,LONN, Hans Roland,CONNOLLY, Stephen,SWALLOW, Steven
申请号：
EP17835331
公开号：
EP3490566A4
申请日:
2017.07.28
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
that inhibit dipeptidyl peptidase 1 (DPP1) activity. Methods provided herein are useful for prophylaxis, increasing the lung function in a patient, and/or and/or decreasing the rate of pulmonary exacerbation in a patient. In one embodiment, the compound of Formula (I) is (2S)—N-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide.
